Isospec Analytics

Curated by Signal

Provider of drug and biomarker discovery for pharmaceutical companies

Overview

Provider of drug and biomarker discovery for pharmaceutical companies. The company has proprietary fingerprinting technology that provides key information during target validation and compound screening for optimal decision-making and development allowing pharmaceutical companies to speed up the drug discovery and development phases by offering a faster and more reliable approach to biomolecular analysis.

Key facts

Founded: 2022
Headquarters: Lausanne, Switzerland
Stage: Sign up to view
Industry: Health Technology

Business model

GTM channel: Sign up to view
2 products and services: Sign up to view

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Derma.one
Digital dermatology workflow management tool for provider
Health TechnologyZurich, Switzerland
Suited Technologies
Provider of ambulatory care software for home care services
Health TechnologyZurich, Switzerland
Virtusan
Mobile app offering multiple fitness and wellness services
Health TechnologyHorw, Switzerland

About Isospec Analytics

What does Isospec Analytics do?

Provider of drug and biomarker discovery for pharmaceutical companies.

Where is Isospec Analytics headquartered?

Isospec Analytics is headquartered in Lausanne, Switzerland.

When was Isospec Analytics founded?

Isospec Analytics was founded in 2022.

Which sector is Isospec Analytics in?

Isospec Analytics operates in Health Technology.

Who are Isospec Analytics's competitors?

Companies similar to Isospec Analytics include Derma.one, Suited Technologies, and Virtusan.